Drug Information

Drug General Information
Drug ID
D0B9UU
Former ID
DNC009424
Drug Name
BW-202W92
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530055]
Formula
C11H8Cl3FN4
Canonical SMILES
C1=C(C=C(C(=C1Cl)Cl)C2=C(N=C(N=C2N)N)CF)Cl
InChI
1S/C11H8Cl3FN4/c12-4-1-5(9(14)6(13)2-4)8-7(3-15)18-11(17)19-10(8)16/h1-2H,3H2,(H4,16,17,18,19)
InChIKey
QEDNOUAODRFJQN-UHFFFAOYSA-N
PubChem Compound ID
9883607
Target and Pathway
Target(s) Voltage-gated sodium channel subunit alpha Nav1.3 Target Info Inhibitor [530055]
Sodium channel protein type 4 subunit alpha Target Info Inhibitor [530055]
Sodium channel Target Info Inhibitor [530055]
Voltage-gated sodium channel subunit alpha Nav1.8 Target Info Inhibitor [530055]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins
References
Ref 530055J Med Chem. 2009 May 14;52(9):2694-707.Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones.
Ref 530055J Med Chem. 2009 May 14;52(9):2694-707.Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones.